戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 s of sucrose octasulfate (SOS), an important pharmaceutical agent.
2 nimidyl ester), used as model of an anionic, pharmaceutical agent.
3 ated on both a complex natural product and a pharmaceutical agent.
4 st in developing equol as a nutraceutical or pharmaceutical agent.
5 comparable with those used in regulating new pharmaceutical agents.
6 lves as leads in the identification of novel pharmaceutical agents.
7 e-activity relations for this novel class of pharmaceutical agents.
8 eins, serving as targets for the majority of pharmaceutical agents.
9 e useful in the development of antimicrobial pharmaceutical agents.
10 nalogues of these compounds may be useful as pharmaceutical agents.
11 ular target for the development of antiviral pharmaceutical agents.
12 n constants, and have been targeted as novel pharmaceutical agents.
13 d protodecarboxylation which widely provided pharmaceutical agents.
14 acellular delivery of a variety of molecular/pharmaceutical agents.
15 ures that are common to natural products and pharmaceutical agents.
16 nds, and streamline the de novo synthesis of pharmaceutical agents.
17 heterocycles, as well as aromatic-containing pharmaceutical agents.
18 fficient routes for the production of active pharmaceutical agents.
19 fety data are required during development of pharmaceutical agents.
20 -based therapeutics are an emerging class of pharmaceutical agents.
21  synthetic intermediates and constituents of pharmaceutical agents.
22  communication, and the targets of different pharmaceutical agents.
23 te-stage N-glycosylation of azole-containing pharmaceutical agents.
24 d library synthesis for the discovery of new pharmaceutical agents.
25  enabling late-stage modification of complex pharmaceutical agents.
26 ed dimeric NRPSs for the production of novel pharmaceutical agents.
27 functionalization of bioactive molecules and pharmaceutical agents.
28 ntrast media (ICM) are commonly administered pharmaceutical agents.
29 responses to physiological stimuli or indeed pharmaceutical agents.
30  to the development of new immunosuppressive pharmaceutical agents.
31 reactions are a mainstay in the synthesis of pharmaceutical agents.
32          C-H bonds are present in almost all pharmaceutical agents.
33 y found in biologically active compounds and pharmaceutical agents.
34 found in many secondary metabolites and some pharmaceutical agents.
35 tant molecules, including polymers, dyes and pharmaceutical agents.
36  are particularly important features of many pharmaceutical agents.
37 that involve tea as well as other dietary or pharmaceutical agents.
38 oactive molecules, including amino acids and pharmaceutical agents.
39 ys an essential role in the synthesis of new pharmaceutical agents.
40 le can be further extended to other toxic or pharmaceutical agents.
41 es, are widely used as antibiotics and other pharmaceutical agents.
42 ct trifluoromethylation of widely prescribed pharmaceutical agents.
43 challenges associated with the design of new pharmaceutical agents.
44 ul in the delivery and controlled release of pharmaceutical agents.
45 HSCT recipient beyond limitations of current pharmaceutical agents.
46 agy to mitigate the damage of treatment with pharmaceutical agents.
47 t a robust protocol for fingerprinting these pharmaceutical agents.
48 is of complex natural products and potential pharmaceutical agents.
49 ent I(Kr), is the unintended target for many pharmaceutical agents.
50 aving the potential of being highly specific pharmaceutical agents.
51 5 mo while treating them with a vehicle or a pharmaceutical agent (4MDM) that selectively augments th
52 s research contributes to the development of pharmaceutical agents against endotoxemia and septic sho
53 pt profile was distinctly different for each pharmaceutical agent and that raloxifene maintained more
54 idines are prevalent in natural products and pharmaceutical agents and are important synthetic target
55 portant building blocks for the synthesis of pharmaceutical agents and biologically active natural pr
56 ent method for assessing the impact of novel pharmaceutical agents and clinical management protocols.
57 igh value of this motif in natural products, pharmaceutical agents and functional materials.
58 stage modification of densely functionalized pharmaceutical agents and natural products.
59 d) are important structural elements in many pharmaceutical agents and natural products.
60  the brain change itself, sometimes aided by pharmaceutical agents and other treatments.
61 portance of these compounds as components in pharmaceutical agents and peptidomimetics.
62                        The active release of pharmaceutical agents and the use of porous sensor membr
63 e high-throughput toxicological screening of pharmaceutical agents and treatment regimens on organoty
64  nature, and also provide core scaffolds for pharmaceutical agents and vaccines.
65 ole in the evaluation and development of new pharmaceutical agents and will be increasingly used in c
66 chemicals, biological probes, and especially pharmaceuticals agents and preclinical candidates.
67 verse effects of abused psychostimulants and pharmaceutical agents, and can be adapted for use in neu
68  and are commonly found in natural products, pharmaceutical agents, and materials.
69 sence in a wide variety of natural products, pharmaceutical agents, and mimics of protein structural
70 ons of DNA and RNA with regulatory proteins, pharmaceutical agents, and other ligands.
71 n an array of bioactive natural products and pharmaceutical agents are often synthesized by asymmetri
72 as stenting, photodynamic therapy, and novel pharmaceutical agents are under consideration as methods
73                                         With pharmaceutical agents as functional anions ([RdrugOPO3](
74 ducts, small-molecule biological probes, and pharmaceutical agents, as evidenced by their prevalence
75 tinue to be important for the development of pharmaceutical agents, as molecules in this class play a
76 materials have the ability to deliver active pharmaceutical agents at a varied concentration levels a
77 , enantioselective synthesis of an important pharmaceutical agent, atomoxetine.
78 at may be inhibited by structurally distinct pharmaceutical agents both in vitro and in vivo.
79 e alterations can limit the effectiveness of pharmaceutical agents but provide new avenues for therap
80 egies, such as self-help, counseling, single pharmaceutical agents, combined pharmacotherapies, and p
81                Notably, structurally complex pharmaceutical agents could be functionalized or prepare
82                                              Pharmaceutical agents currently approved for the treatme
83                                    While the pharmaceutical agents decreased mitochondrial membrane p
84 tory effects on one another, suggesting that pharmaceutical agents designed to inhibit NOS2 or COX-2
85 pecifically, and novel techniques to deliver pharmaceutical agents directly to HSC, potentially allow
86                                              Pharmaceutical agents, drugs of abuse, and toxic substan
87  production errors, or by contamination with pharmaceutical agents, either as a result of poor manufa
88 erse range of reports from this field aim at pharmaceutical agent encapsulation, targeted drug-delive
89 ducts in good yields (75-99%), including the pharmaceutical agents fenpiprane and prozapine.
90 benefits and minimize the adverse effects of pharmaceutical agents for NAFLD.
91 allenges not shared in the usual paradigm of pharmaceutical agents for prevention of cardiovascular d
92 bute to the development of a novel family of pharmaceutical agents for the improvement of the healing
93 rtant carbon-containing molecules, including pharmaceutical agents, fragrances and polymers.
94 ew US Food and Drugs Administration approved pharmaceutical agents further eliminate testosterone lig
95 including metabolites, mitogens, toxins, and pharmaceutical agents, generating robust and scalable re
96 r the completion of treatment during which a pharmaceutical agent has maximum access to high-grade gl
97      Induction of cell differentiation using pharmaceutical agents has been clinically attempted for
98                                 A variety of pharmaceutical agents has been proposed for use in perio
99 s, the approval and regulation processes for pharmaceutical agents have evolved and increased in comp
100                                 No effective pharmaceutical agents have yet been identified to treat
101 rophenol and resorcinol) and a few important pharmaceutical agents (i.e., hexobarbital, oxazepam, and
102                                       Of the pharmaceutical agents identified, there was enrichment f
103      Therefore, 4SC-101 might be a promising pharmaceutical agent in Tx medicine for further investig
104 re increasingly being developed as potential pharmaceutical agents in targeting metalloenzymes.
105 le as well as provide benefit beyond that of pharmaceutical agents in treating heart disease.
106  We review available articles characterizing pharmaceutical agents including alpha receptor antagonis
107 ne and the formal synthesis of several other pharmaceutical agents, including duloxetine, atomoxetine
108 eaction should be applicable to a variety of pharmaceutical agents, including NO synthase inhibitors,
109 ction in nanoscale drug delivery systems for pharmaceutical agents, including small molecules, protei
110       These findings shed light on how these pharmaceutical agents interact and how treated cells aug
111         The different aspects of introducing pharmaceutical agents into the pores of these nanocarrie
112                                       When a pharmaceutical agent is encapsulated within, or attached
113 ips with constituent biological entities and pharmaceutical agents is crucial for drug design and dis
114  CAR system regulated by clinically approved pharmaceutical agents is needed.
115          To fully develop their potential as pharmaceutical agents it is necessary to understand both
116                             Furthermore, new pharmaceutical agents moderating the intracellular and e
117    Across many classes of molecule-including pharmaceutical agents, natural products, agrochemicals,
118 rous interesting molecules such as peptides, pharmaceutical agents, naturally occurring molecules, pr
119                                Ajmaline is a pharmaceutical agent now administered globally for a var
120              A variety of these biologic and pharmaceutical agents offer promise as potential therapi
121    Thus, pHLIP could be used for delivery of pharmaceutical agents or imaging probes to the myocardia
122 in ill-defined and there are no FDA approved pharmaceutical agents or medical countermeasures.
123 l products have led to the discovery of many pharmaceutical agents, particularly antibiotics.
124 rough one-step syntheses of two high-profile pharmaceutical agents, Plavix and amfepramone.
125 eukotriene A4 aminopeptidase activity with a pharmaceutical agent protected murine lungs from develop
126  concentrations similar to those achieved by pharmaceutical agents, remarkably little is known about
127 rbon-monoxide-releasing molecules (CORMs) as pharmaceutical agents represents an attractive and safer
128 useful with respect to in vivo monitoring of pharmaceutical agents selected for their ability to prev
129      Investigations have explored the use of pharmaceutical agents such as capsaicin and other Transi
130                                              Pharmaceutical agents such as valproate, which counterac
131                                     Although pharmaceutical agents targeting multiple biological path
132 s in the preclinical evaluation of candidate pharmaceutical agents targeting protein-protein interact
133 e avoided with the use of existing and novel pharmaceutical agents targeting specific inflammatory me
134 -coupled receptor (GPCR), yet relatively few pharmaceutical agents targeting this visual receptor hav
135 n channel inhibitors suggests the effects of pharmaceutical agents (TEA on HeLa; DMSO and neuraminida
136                             A range of novel pharmaceutical agents that aim to target liposarcoma-spe
137       Myosin modulators are a novel class of pharmaceutical agents that are being developed to treat
138                               While studying pharmaceutical agents that can target B-catenin in cance
139                               While studying pharmaceutical agents that can target beta-catenin in ca
140                                              Pharmaceutical agents that could suppress the induced ex
141              We report the identification of pharmaceutical agents that enhance VH and use these agen
142                                              Pharmaceutical agents that inhibit the ADGRF5 pathway in
143 C(sp(3))-N bonds, a linkage of high value in pharmaceutical agents that is challenging to access via
144                               Treatment with pharmaceutical agents that regulate or are metabolized b
145                         We discuss available pharmaceutical agents that target a critical component o
146 ionale for the 10-mer and its derivatives as pharmaceutical agents that target specific cell growth.
147 n relationships and to improve the design of pharmaceutical agents that target specific RNA motifs, a
148 r of derivatives of 1 are being developed as pharmaceutical agents, the similarity of the chemistry o
149 proteins have been increasingly important as pharmaceutical agents, their chemical and physical insta
150 ugh naked antibodies have proven valuable as pharmaceutical agents, they have some limitations, such
151 y extended intervals from the inception of a pharmaceutical agent to its eventual launch in the marke
152 nately, the use of brain-derived peptides as pharmaceutical agents to alter brain chemistry in vivo h
153  studies conducted to investigate the use of pharmaceutical agents to retard or cure the loss of cone
154 strategies involves the targeted delivery of pharmaceutical agents to the site of bone cancer by intr
155              Transduction can be enhanced by pharmaceutical agents up to sevenfold in primary cells (
156                              Dipyridamole, a pharmaceutical agent used for the first time as a fluore
157                           Unlike many of the pharmaceutical agents used in patients with coronary art
158 rementioned parameters and on consumption of pharmaceutical agents was assessed.
159 ocycles in biologically active alkaloids and pharmaceutical agents, we envisage that our method will
160 ce that were 4 to 48 weeks old for screening pharmaceutical agents, we have demonstrated age- and sex
161           More than 50 complex molecules and pharmaceutical agents were efficiently labeled with fluo
162 glumine, an MR-detectable model representing pharmaceutical agents, were then injected intravenously.
163                                              Pharmaceutical agents which would prevent the induced ex
164  environment interactions, and they serve as pharmaceutical agents with antimicrobial and anti-tumor
165 al is made for physicians to prescribe those pharmaceutical agents with definitive evidence of mortal
166 duced by curcumin can potentially lead to AD pharmaceutical agents with inherent bio-compatibility.
167 ound targeted the delivery of macromolecular pharmaceutical agents within tissues.

 
Page Top